Incyte (INCY) announced new data from a phase I study on pipeline candidate INCB123667 in patients with advanced solid tumors. INCB123667 is a highly selective, potential first-in-class CDK2 inhibitor. The new data was presented during a mini-oral presentation at the European Society of Medical Oncology. The updated data highlight the potential of the candidate as a differentiated treatment option for cancers with increased cyclin E1 activity, amplification and/or overexpression in cells predictive of CDK2 ...

VTEX (VTEX) is a Zacks Rank #1 (Strong Buy) that has an F for Value and a B for Growth. This is a software-as-a-service digital commerce platform for retailers. VTEX helps companies develop a commerce strategy and build online stores and market their product or service. Let's explore more about this company in this Bull of The Day article. Description VTEX provides software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables its customers to execute its commerce ...

Mastercard Incorporated (MA) recently teamed up with the urban rail transit system of Beijing and made an announcement that international visitors can now use Tap & Go payments at all urban rail transit stations of China's capital with overseas-issued Mastercard cards. The facility was made available for the targeted individuals from Friday. This Tap & Go service enables inbound travelers to easily access more than 10,000 gates across around 490 urban rail transit stations in Beijing without needing cash or ...

In recent months, we've witnessed a significant rotation in the stock market, with investors gravitating toward defensive, value-oriented stocks as they brace for an economic slowdown and potential shifts in interest rate policy.This flight to safety has caused many value stocks—traditionally considered stable but slow-growing—to become highly sought after, driving their valuations higher. At the same time, tech stocks, known for their growth potential, have seen their prices drop, creating an unusual dynam ...

Regeneron Pharmaceuticals, Inc. (REGN) announced that the FDA has approved blockbuster drug Dupixent (dupilumab) for the indication of chronic rhinosinusitis with nasal polyps (CRSwNP) for a broader population.The regulatory body approved the drug as an add-on maintenance treatment for adolescent patients aged 12 to 17 years with inadequately controlled CRSwNP.The latest approval expands the initial FDA approval (granted in June 2019) in CRSwNP for patients aged 18 years and older.Regeneron’s shares have ra ...

Amazon CEO Andy Jassy sent a memo to the company’s employees Monday morning, calling for a full return to office at the start of 2025.For the last fifteen months, Amazon employees have been expected to work in the office three days per week. Now, Jassy expects five days of in-person work from employees, with the caveat that work from home is okay in extenuating circumstances, like if an employee’s child is sick.“When we look back over the last five years, we continue to believe that the advantages of being ...

hirun Devon Energy Corporation (NYSE:DVN) is a U.S. hydrocarbon company with a valuation of roughly $25 billion. The company has a dividend yield of more than 5% and is committed to generating strong shareholder returns, which it's built a history of doing so recently. As we'll see throughout this article, Devon Energy can continue generating strong shareholder returns. Devon Energy Business Model The company's business model centers around growing its production and increasing overall shareholder retur ...

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock or sellers of puts of MacroGenics, Inc. (NASDAQ: MGNX) between March 7, 2024 and May 9, 2024, both dates inclusive (the “Class Period”), of the important September 24, 2024 lead plaintiff deadline. SO WHAT: If you purchased stock or sold puts of MacroGenics during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a con ...

"If anything, the last 15 months we've been back in the office at least three days a week has strengthened our conviction about the benefits," Jassy said.Jassy also said the company will flatten its org-chart by the end March 2025, with a 15% increase of individual contributors assigned to each manager.If you are an Amazon worker who wants to share your perspective, please contact Dominick via email or text/call/Signal at 646.768.4750. Responses will be kept confidential, and Business Insider strongly recom ...

Key TakeawaysIntel has reportedly won $3.5 billion in grants from the Pentagon to manufacture chips for the U.S. military.Bloomberg reported that Intel's work will be part of the government's Secure Enclave program, which aims to produce advanced chips with military and intelligence applications. The contract comes on top of the potential $8.5 billion in grants and $11 billion in loans that Intel was awarded earlier this year from the CHIPS and Science Act of 2022. Shares of Intel (INTC) advanced Monday, ai ...